mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 55 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 3,806,432 | 0 | A | C | 70.8% | 6.8 / 18.4 | 24 | T114T (ACA→ACC) | coaBC | bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate‑‑cysteine ligase CoaBC |
| * | NZ_CP009273 | 822,963 | 0 | T | G | 68.8% | 1.5 / 11.7 | 16 | D492A (GAC→GCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 1,512,405 | 0 | A | C | 62.5% | 7.7 / 16.4 | 16 | F62V (TTT→GTT) | ydcZ | DMT family transporter |
| * | NZ_CP009273 | 1,407,992 | 0 | A | T | 61.5% | ‑4.9 / 13.0 | 13 | Y2* (TAT→TAA) *65K (TAA→AAA) | rcbA ralR | double‑strand break reduction protein RcbA type I toxin‑antitoxin system endodeoxyribonuclease toxin RalR |
| * | NZ_CP009273 | 822,955 | 0 | T | G | 61.1% | 6.9 / 17.5 | 18 | T495P (ACC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 832,048 | 0 | T | G | 60.0% | 10.2 / 19.7 | 20 | V81G (GTC→GGC) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
| * | NZ_CP009273 | 536,014 | 0 | T | G | 58.3% | 3.8 / 12.6 | 12 | intergenic (+50/‑7) | allB/ybbY | allantoinase AllB/uracil/xanthine transporter |
| * | NZ_CP009273 | 832,042 | 0 | C | G | 57.9% | 5.1 / 18.8 | 20 | A79G (GCG→GGG) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
| * | NZ_CP009273 | 1,679,006 | 0 | A | C | 57.1% | 9.0 / 16.1 | 14 | D164A (GAC→GCC) | tus | DNA replication terminus site‑binding protein |
| * | NZ_CP009273 | 3,774,215 | 0 | T | G | 56.8% | 24.6 / 34.7 | 37 | G343G (GGT→GGG) | lldD | quinone‑dependent L‑lactate dehydrogenase |
| * | NZ_CP009273 | 760,200 | 0 | A | T | 56.2% | 7.6 / 18.4 | 16 | I189F (ATC→TTC) | sucD | succinate‑‑CoA ligase subunit alpha |
| * | NZ_CP009273 | 1,370,606 | 0 | A | C | 56.2% | 17.4 / 21.1 | 16 | T106P (ACC→CCC) | ycjR | sugar phosphate isomerase/epimerase |
| * | NZ_CP009273 | 4,290,979 | 0 | T | G | 56.2% | 13.1 / 18.9 | 16 | T639T (ACA→ACC) | mdtO | multidrug efflux transporter permease subunit MdtO |
| * | NZ_CP009273 | 3,726,640 | 0 | T | A | 56.0% | 4.5 / 34.1 | 25 | N360K (AAT→AAA) | xylG | D‑xylose ABC transporter ATP‑binding protein |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 55.8% | 10.2 / 49.6 | 43 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 55.8% | 15.5 / 53.6 | 43 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 822,957 | 0 | A | G | 55.6% | 9.5 / 18.4 | 18 | L494P (CTC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 2,436,061 | 0 | T | G | 55.6% | 14.6 / 24.0 | 18 | G273G (GGT→GGG) | mnmC | bifunctional tRNA (5‑methylaminomethyl‑2‑thiouridine)(34)‑methyltransferase MnmD/FAD‑dependent 5‑carboxymethylaminomethyl‑2‑thiouridine(34) oxidoreductase MnmC |
| * | NZ_CP009273 | 1,408,011 | 0 | A | T | 54.5% | 4.2 / 10.6 | 11 | N58K (AAT→AAA) | ralR | type I toxin‑antitoxin system endodeoxyribonuclease toxin RalR |
| * | NZ_CP009273 | 3,659,058 | 0 | T | C | 54.0% | 41.8 / 53.8 | 37 | D38G (GAT→GGT) | gadX | acid resistance transcriptional activator GadX |